1989
DOI: 10.1016/0020-7292(89)90762-5
|View full text |Cite
|
Sign up to set email alerts
|

Current status of genitourinary fistula

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
131
1
8

Year Published

1993
1993
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 126 publications
(146 citation statements)
references
References 0 publications
5
131
1
8
Order By: Relevance
“…In developed countries, VVF mostly occurs due to iatrogenic injury secondary to gynecologic surgery, of which hysterectomy is the leading cause. Recently reported rate of VVF during hysterectomy is 1 in 788 [3][4][5]. In developing countries, poor obstetric care is the leading cause of VVF [2,6].…”
Section: Introductionmentioning
confidence: 99%
“…In developed countries, VVF mostly occurs due to iatrogenic injury secondary to gynecologic surgery, of which hysterectomy is the leading cause. Recently reported rate of VVF during hysterectomy is 1 in 788 [3][4][5]. In developing countries, poor obstetric care is the leading cause of VVF [2,6].…”
Section: Introductionmentioning
confidence: 99%
“…The results will depend on the elapsed time since the fistulous tract has been made, its etiology, the quantity of necrotic tissue present, the surgical technique and the experience of the surgeon. [6,7] The VVF should be repaired immediately or at the latest, 24-48 hours after it has occurred. After 48 hours, the repair's effectiveness remains controversial.…”
Section: Discussionmentioning
confidence: 99%
“…40,41 However, in the developing countries, obstetric fistulae are common. 42 Estimates indicate that 2-3 millions women live with obstetric fistulae worldwide, the majority of whom are in Africa and Asia.…”
Section: Fistulae In the Developing Worldmentioning
confidence: 99%
“…75 Duloxetine (Yentreve®) is a potent serotonin/noradrenaline reuptake inhibitor (SNRI), approved by the European Medicines Agency (EMA) in 2004, and represents a major therapeutic advance for the treatment of SUI. 76 Clinical trials showed that duloxetine; at the recommended dose of 40 …”
Section: Drugs With Mixed Actionsmentioning
confidence: 99%